首頁 > 市場調查報告書 > 醫療設備

體外診斷

血液凝固檢驗市場規模、佔有率和成長分析（按產品、檢測方法、技術、應用、最終用戶和地區分類）—產業預測，2026-2033年

市場調查報告書

商品編碼

1898325

血液凝固檢驗市場規模、佔有率和成長分析（按產品、檢測方法、技術、應用、最終用戶和地區分類）—產業預測，2026-2033年

Coagulation Testing Market Size, Share, and Growth Analysis, By Product (Instruments, Consumables), By Test (Complete Blood Count (CBC), Factor V Assay), By Technology, By Application, By End-User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月17日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，血液凝固檢驗市場規模將達到 42.6 億美元，到 2025 年將達到 47.8 億美元，到 2033 年將達到 120.1 億美元，在預測期（2026-2033 年）內，複合年成長率為 12.2%。

受多種因素驅動，全球血液凝固檢驗市場正經歷顯著成長。血液凝固檢驗對於診斷和監測各種血液凝固相關疾病至關重要，而這些疾病與心血管疾病、血友病和血管性血友病等血液疾病的日益普遍密切相關。此外，需要精準診斷的外科手術和創傷病例數量的增加也進一步推動了對血液凝固檢驗的需求。同時，診斷產品和設備的嚴格監管要求在塑造市場格局方面發揮關鍵作用，迫使新參與企業必須達到品質標準並獲得監管部門的核准。所有這些因素共同凸顯了血液凝固檢驗在現代醫學中的關鍵地位。

血液凝固檢驗市場促進因素

心血管疾病發生率的上升和全球人口老化凸顯了血液凝固檢驗作為關鍵診斷手段日益成長的需求。此外，光學和電化學血液凝固檢驗檢測等診斷技術的創新，提高了檢測結果的準確性和效率，從而促進了這些檢測方法在各種醫療機構中的應用和普及。這些因素不僅凸顯了血液凝固檢驗在患者管理中的重要性，也推動了其持續發展以滿足日益成長的醫療需求。因此，這些發展共同推動了血液凝固檢驗市場的擴張。

血液凝固檢驗市場的限制因素

血液凝固檢驗市場面臨的主要阻礙因素是檢測方法標準化的挑戰，尤其是不同檢查室和環境下檢測結果的差異。這些不一致給醫療專業人員準確解讀檢測結果帶來了困難，影響了血液凝固檢驗的整體可靠性。因此，結果的不一致會阻礙有效的診斷和治療，妨礙患者照護，並影響醫療專業人員和患者對檢測過程的信心。解決這些標準化難題對於提高血液凝固檢驗實踐的一致性和可靠性至關重要。

血液凝固檢驗市場趨勢

血液凝固檢驗市場正經歷著向就地檢驗（POC檢測）的顯著轉變，這主要得益於對快速、分散式診斷解決方案日益成長的需求。這種轉變的主要驅動力是急診和門診環境中對快速決策的需求，因為及時獲得檢測結果對患者預後至關重要。技術進步使得高度便攜、易於操作的血液凝固檢驗設備得以開發，並正被擴大應用於各種醫療機構。隨著醫療服務提供者將效率和以患者為中心的護理放在首位，這些創新檢測解決方案的應用預計將持續成長，並重塑凝血診斷領域。

Roche Diagnostics（Switzerland）
Siemens Healthineers（Germany）
Abbott Laboratories（USA）
Instrumentation Laboratory（Werfen）（Spain）
Sysmex Corporation（Japan）
Thermo Fisher Scientific Inc.（USA）
bioMerieux SA（France）
Diagnostica Stago SAS（France）
Horiba, Ltd.（Japan）
Alere Inc.（USA）（now Abbott）
Haemonetics Corporation（USA）
Helena Laboratories Corporation（USA）
Medtronic plc（Ireland）
Agilent Technologies, Inc.（USA）
Sekisui Diagnostics（Japan）
Trinity Biotech plc（Ireland）
Kyowa Medex Co., Ltd.（Japan）
Maccura Biotechnology Co., Ltd.（China）

結論與建議

簡介目錄

Product Code: SQMIG35G2268

Coagulation Testing Market size was valued at USD 4.26 Billion in 2024 and is poised to grow from USD 4.78 Billion in 2025 to USD 12.01 Billion by 2033, growing at a CAGR of 12.2% during the forecast period (2026-2033).

The global Coagulation Testing Market is experiencing substantial growth, driven by several influencing factors. Coagulation testing is essential for diagnosing and monitoring various medical conditions related to blood clotting, aligning with the increasing prevalence of cardiovascular diseases and blood disorders, including hemophilia and von Willebrand disease. The demand for coagulation testing is further fueled by the rising number of surgical procedures and trauma cases that require precise diagnostics. Additionally, stringent regulatory requirements for diagnostic products and devices play a crucial role in shaping the market landscape, necessitating compliance with quality standards and regulatory approvals for new market entrants. This combination of factors highlights the critical importance of coagulation testing in modern healthcare.

Top-down and bottom-up approaches were used to estimate and validate the size of the Coagulation Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Coagulation Testing Market Segments Analysis

Global Coagulation Testing Market is segmented by Product, Test, Technology, Application, End-User and region. Based on Product, the market is segmented into Instruments, Consumables, Reagents And Standards, Controls and Calibrations. Based on Test, the market is segmented into Complete Blood Count (CBC), Factor V Assay, Fibrinogen Level, Prothrombin Time, Platelet Count, Thrombin Time, Bleeding Time and Others. Based on Technology, the market is segmented into Optical Technology, Mechanical Technology, Electrochemical Technology and Others. Based on Application, the market is segmented into Activated Clotting Time (ACT), Thrombin Time (TT), Partial Thromboplastin Time (PTT), Activated Partial Thromboplastin Time (APTT), Prothrombin Time (PT) and Other. Based on End-User, the market is segmented into Hospitals, Clinical Laboratories, Point-of-Care Testing and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Coagulation Testing Market

The rising incidence of cardiovascular diseases, along with a worldwide aging population, highlights the escalating demand for coagulation testing as a crucial diagnostic resource. Moreover, innovations in diagnostic technology, such as optical and electrochemical coagulation testing methods, contribute to improved precision and efficiency of results. This leads to greater acceptance and implementation of these tests in various healthcare environments. The convergence of these factors not only emphasizes the importance of coagulation testing in patient management but also propels its continuous evolution to meet the growing healthcare needs. Consequently, these developments collectively drive the expansion of the coagulation testing market.

Restraints in the Coagulation Testing Market

A significant restraint within the coagulation testing market lies in the challenges related to the standardization of testing methodologies, particularly due to variations in results among different laboratories and environments. These discrepancies can create difficulties for healthcare professionals in accurately interpreting test outcomes, thereby impacting the overall reliability of coagulation testing. As a result, the inconsistency of results can hinder effective diagnosis and treatment, posing a hurdle in delivering optimal patient care and affecting the confidence of both practitioners and patients in the testing process. Addressing these standardization issues is crucial to enhance the coherence and trustworthiness of coagulation testing practices.

Market Trends of the Coagulation Testing Market

The coagulation testing market is experiencing a notable trend towards point-of-care testing, driven by the increasing demand for rapid and decentralized diagnostic solutions. This shift is primarily motivated by the necessity for swift decision-making in emergency and outpatient scenarios, where timely results can significantly impact patient outcomes. Advances in technology are enabling the development of portable, user-friendly coagulation testing devices, which are being embraced across diverse healthcare settings. As healthcare providers prioritize efficiency and patient-centric care, the adoption of these innovative testing solutions is expected to grow, reshaping the landscape of coagulation diagnostics.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Coagulation Testing Market Size by Product & CAGR (2026-2033)

Market Overview
Instruments
Consumables
Reagents And Standards
Controls
Calibrations

Global Coagulation Testing Market Size by Test & CAGR (2026-2033)

Market Overview
Complete Blood Count (CBC)
Factor V Assay
Fibrinogen Level
Prothrombin Time
Platelet Count
Thrombin Time
Bleeding Time
Others

Global Coagulation Testing Market Size by Technology & CAGR (2026-2033)

Market Overview
Optical Technology
Mechanical Technology
Electrochemical Technology
Others

Global Coagulation Testing Market Size by Application & CAGR (2026-2033)

Market Overview
Activated Clotting Time (ACT)
Thrombin Time (TT)
Partial Thromboplastin Time (PTT)
Activated Partial Thromboplastin Time (APTT)
Prothrombin Time (PT)
Other

Global Coagulation Testing Market Size by End-User & CAGR (2026-2033)

Market Overview
Hospitals
Clinical Laboratories
Point-of-Care Testing
Others

Global Coagulation Testing Market Size & CAGR (2026-2033)

North America (Product, Test, Technology, Application, End-User)
- US
- Canada
Europe (Product, Test, Technology, Application, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Test, Technology, Application, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Test, Technology, Application, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Test, Technology, Application, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Instrumentation Laboratory (Werfen) (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Diagnostica Stago SAS (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Horiba, Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alere Inc. (USA) (now Abbott)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Haemonetics Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Helena Laboratories Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sekisui Diagnostics (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trinity Biotech plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kyowa Medex Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Maccura Biotechnology Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments